UroGen Pharma Ltd. announced effective April 1, 2020, the following individuals will be promoted to the following roles: Jeff Bova to Chief Commercial Officer; and Elyse Seltzer to MD, Chief Development Officer. . Bova joined UroGen in 2017 and most recently served as UroGen’s Senior Vice President of Commercial. Dr. Seltzer joined UroGen in 2017 and most recently served as UroGen’s Senior Vice President of Clinical Development.